| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 567 | 291 | 282 | 32 |
The journal mainly tackles studies in Internal medicine, Oncology, Cancer research, Chemotherapy and Cancer. The Internal medicine study presented in the journal encompasses related topics like Clinical trial, Immunotherapy, Lung cancer and Colorectal cancer and also examines its connection to subjects such as In patient. Therapeutic Advances in Medical Oncology explores the study of Clinical trial to improve our understanding of the broader topic of Pathology.
Research on Immunotherapy presented in it concerns the broader topic of Immune system. Non small cell is a major topic of Lung cancer research. Therapeutic Advances in Medical Oncology deals with Oncology in conjunction with Targeted therapy and similar fields in Melanoma.
The studies on Cancer research discussed can also contribute to research in the domains of Epidermal growth factor receptor, Bioinformatics, Carcinogenesis, Tyrosine kinase and Metastasis. The study of Chemotherapy, which falls within the realm of Surgery, was the main focus of the presentations. The presentations discussing Breast cancer offer insights in topics such as Metastatic breast cancer, Triple-negative breast cancer and Trastuzumab.
Internal medicine, Oncology, Cancer research, Clinical trial and Cancer are the main subjects of interest in the most cited publications. The most cited papers with studies in Oncology featured incorporate elements of Disease, Pathology, Targeted therapy, Colorectal cancer and Immunotherapy. The journal publications tackle studies in Intensive care medicine and the interrelated subject of Fluorouracil to gain insights into Cancer.
The journal mainly deals with areas of study such as Internal medicine, Oncology, Cancer research, Chemotherapy and Immunotherapy. The journal tackles research in Cancer, Colorectal cancer, Clinical trial and Bevacizumab as part of the general discipline of Internal medicine, however, it also discusses concepts in In patient. Oncology research featured in Therapeutic Advances in Medical Oncology incorporates concerns from various other topics such as Breast cancer, Trastuzumab, Disease and Targeted therapy.
It addresses concerns in the field of Cancer research by exploring it in line with topics in Non small cell which intersect with Phases of clinical research and Cisplatin subjects. Topics in Chemotherapy were tackled in line with various other fields like Meta-analysis, Adverse effect and Pathological. While the journal focused on Immunotherapy, it was also able to explore topics like Bladder cancer and Standard treatment.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Therapeutic Advances in Medical Oncology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Therapeutic Advances in Medical Oncology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 9.30% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.06% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.55% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.37% of all publications and 41.03% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
As evidenced by the diversity of research topics covered in this journal, the field of Medical Oncology offers numerous career opportunities and paths for prospective oncologists, researchers and medical practitioners. Whether you aim to contribute to cutting-edge research in cancer, engage in clinical trials for new treatments, or provide specialist care for patients with cancer as a dedicated physician, the opportunities are vast and varied.
One such path to consider is becoming a Nurse Practitioner specialized in Oncology. As a Nurse Practitioner in Oncology, you can make meaningful contributions to patient care and research. Nurse practitioners often engage in clinical trials, contribute to research papers, and are crucial to advancements in patient care, making them a key part of the oncology community.
If this particular career path interests you and you're currently based or wish to practice in Pennsylvania, you might be interested in checking out the specific nurse practitioner program requirements pennsylvania. This would provide you with the necessary understanding of the study duration, application process, costs, and a glimpse into the course structure for this specialized program as outlined by the Pennsylvania State Board of Nursing.
Regardless of the career path you choose in the field of Medical Oncology, staying up-to-date with the latest research, such as that published in the Therapeutic Advances in Medical Oncology journal, will always be an invaluable tool in aspiring to provide the best patient care and innovative solutions in oncology.
Elie Rassy;Ronan Flippot;Laurence Albiges
(2020)Aiko Nagayama;Neelima Vidula;Leif Ellisen;Aditya Bardia
(2020)Pauline du Rusquec;Cyriac Blonz;Jean Sebastien Frenel;Mario Campone
(2020)Sara Elena Rebuzzi;Alessio Signori;Giuseppe Luigi Banna;Marco Maruzzo
(2021)Morena Fasano;Carminia Maria Della Corte;Giuseppe Viscardi;Raimondo Di Liello
(2021)Alexandra Leary;David Tan;Jonathan Ledermann
(2021)For those interested in expanding their expertise beyond traditional medical training, several online degree programs offer valuable career pathways. A doctorate in healthcare administration online prepares professionals to manage healthcare systems effectively, combining leadership skills with a deep understanding of policy and operations.
Pharmacy is another critical field closely linked to medicine. Pursuing an online pharmd provides flexible options for those wanting to advance in pharmaceutical sciences without interrupting clinical work or other commitments.
Specializing in physical health and rehabilitation, an online exercise science degree equips students with knowledge about human movement, fitness, and injury prevention, paving the way for careers in wellness and sports medicine.
Similarly, earning an online bachelor's in kinesiology builds a strong foundation in the mechanics of body movement, supporting roles in physical therapy, athletic training, and rehabilitation services.
Exploring these related online degrees can complement a medical career or serve as alternative pathways into the healthcare sector, reflecting the broad opportunities within health sciences today.
